Cleared Traditional

K855095 - S.L.T. CONTACT LASER ND:YAG USE IN PULM...

K855095 is an FDA 510(k) clearance for S.L.T. CONTACT LASER ND:YAG USE IN PULM..., manufactured by Surgical Laser Technologies, Inc.. The device is a Class 2 Anesthesiology device with product code LLO cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K855095 · Surgical Laser Technologies, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1986
Decision
57d
Days
Class 2
Risk

K855095 is an FDA 510(k) clearance for the S.L.T. CONTACT LASER ND:YAG USE IN PULMONARY AIRWA. Classified as Laser, Neodymium:yag, Pulmonary Surgery (product code LLO), Class II - Special Controls.

Submitted by Surgical Laser Technologies, Inc. (Cincinnati, US). The FDA issued a Cleared decision on February 18, 1986 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 874.4500 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Surgical Laser Technologies, Inc. devices

FDA 510(k) Submission Details - K855095

510(k) Number K855095 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 1985
Decision Date February 18, 1986
Days to Decision 57 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 140d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLO Device Classification - Class 2, Special Controls

Product Code LLO Laser, Neodymium:yag, Pulmonary Surgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.4500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - LLO Laser, Neodymium:yag, Pulmonary Surgery

All 8
Devices cleared under the same product code (LLO) and FDA review panel - the closest regulatory comparables to K855095.
6000 ND:YAG LASER FOR BENIGN/MALIGNANT OBSTRUCTION
K862698 · Cooper Lasersonics, Inc. · Aug 1986
LASER BRONCHOSCOPE SYSTEM
K861921 · Pilling Co. · Jun 1986
CO2 LASER BRONCHOSCOPE SYSTEM
K861583 · Richard Wolf Medical Instruments Corp. · May 1986
ND: YAGLASER FOR PALLIATIVE TREAT OF OBSTRUCTION
K852507 · Endo Lase, Inc. · Jul 1985
LASER BENIGN & MALIGNANT PULMONARY OBSTRUCTIONS-
K850432 · Cooper Lasersonics, Inc. · Feb 1985